12 min read
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition characterized by persistent patterns of inattention, hyperactivity, and impulsivity that begin in early childhood. Globally, it affects roughly 5% of children and adolescents, making it one of the most common developmental conditions encountered by healthcare professionals.
It is important to remember that ADHD is a medical condition, not a reflection of parenting styles, nor is it a child simply "acting up."
How ADHD Presents: The Three Core Types
ADHD does not look the same in every young person. Clinical standards categorize the condition into three distinct presentations based on which traits are most prominent:
- Predominantly Inattentive Presentation: Children may struggle to focus, frequently make careless errors in schoolwork, struggle with organization, lose track of belongings, or easily get distracted by unrelated thoughts. Girls are more likely to present with this presentation, which means their symptoms are often quiet and can easily be overlooked in a quiet classroom.
- Predominantly Hyperactive-Impulsive Presentation: This features physical restlessness, such as constant fidgeting, squirming, an inability to remain seated, excessive talking, or blurting out answers before a question is finished.
- Combined Presentation: The most common form, where a young person exhibits significant features of both inattention and hyperactivity-impulsivity.
The Pathway to a Diagnosis
If you suspect your child or teenager has ADHD, the National Institute for Health and Care Excellence (NICE) guidelines emphasize that a comprehensive, structured evaluation is necessary.
According to NICE guidelines and international clinical criteria, a valid diagnosis requires several clear benchmarks:
- Pervasiveness: Symptoms must be present in at least two separate settings of daily life (e.g., both at home and at school)
- Significant Impairment: The traits must cause distinct social, academic, or behavioral challenges that interrupt their everyday development.
- Age of Onset: Recognizable symptoms must have been present before the age of 12.
Evidence-Based Treatment Options
The treatment strategy recommended by NICE depends primarily on the age of the young person and how severely the symptoms impact their life.
1. Environmental Modifications (All Age Groups)
Before introducing targeted therapies, clinicians look at environmental modifications. This includes restructuring the physical and social environment at home or school—such as optimizing classroom seating, breaking school tasks into smaller blocks, and establishing consistent daily routines.
2. Psychological & Behavioral Interventions
- For Pre-School Children (Under 5): NICE guidelines advocate for specialized, ADHD-focused parent training programs as the primary, first-line intervention. Medication is generally not recommended for this age group.
- For School-Aged Children and Adolescents: Cognitive Behavioral Therapy (CBT), social skills training, and behavioral modifications can be highly beneficial, especially when combined with medication or if a family prefers to avoid medication.
3. Pharmacological Treatment (Medication)
For children aged 5 and older and young people, NICE guidelines state that medication should be considered if symptoms continue to cause a significant impairment in their daily life despite environmental adjustments.
The primary medications prescribed fall into two main categories:
- Stimulants (First-Line): Methylphenidate is recommended as the first-line drug option for children and teenagers. Other common stimulants include Lisdexamfetamine.
- Non-Stimulants (Second-Line): Medications like Guanfacine or Atomoxetine may be prescribed if stimulants are ineffective, cause unmanageable side effects, or are medically unsuitable.
What to Expect During Medical Treatment
Before any medication is written, your child will undergo a full baseline assessment evaluating their physical health (heart rate, blood pressure, height, and weight), mental health history, and social circumstances.
Once a medication is introduced, it involves a process called titration—starting with a low dose and adjusting it upward carefully under specialist care to achieve optimal symptom control with minimal side effects.
NICE guidelines mandate ongoing monitoring, requiring physical check-ups at least every 6 months to ensure your child's growth, sleep quality, and cardiovascular health remain completely on track.
References
- 1. Attention-deficit hyperactivity disorder. (2020). The Lancet, 395(10222), 450-462.
- 2. Attention deficit hyperactivity disorder: diagnosis and management | Guidance - NICE. (2018). National Institute for Health and Care Excellence (NICE).
- 3. Diagnosis and management of ADHD: Summary of NICE guidance. (2020). Hospital Pharmacy Europe.
- 4. Faltinsen, E., Zwi, M., Castells, X., Gluud, C., Simonsen, E., & Storebø, O. J. (2018). Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look. BMJ Evidence-Based Medicine, 24(3), 99-102.
- 5. Kavanagh, G., O'Hanrahan, S., Hughes, G., & McNicholas, F. (2014). Review of clinical guidelines for children and adolescents with attention deficit hyperactivity disorder and their application to an Irish context. Irish Journal of Psychological Medicine, 32(3), 283-293.
- 6. Rationale and impact | Attention deficit hyperactivity disorder: diagnosis and management | Guidance | NICE. (2018). National Institute for Health and Care Excellence (NICE).